Fördubbling av försäljningen Försäljningen uppgick till 50 mkr vilket var en fördubbling y/y (26), f...
Rapportkommentar Corline levererade en rapport för Q1 2022 som var i linje med våra förväntningar.
Redeye states that Frams Q1’22 report was overall stronger than expected
Redeye leaves its comments on InDex Pharmaceuticals following its Q1 2022 report.
Alltainer publicerade idag den 17 maj sin delårsrapport för bolagets tredje kvartal 2021/2022, för p...
Redeye comments on Immunicum communicating interim data from its ADVANCE II trial, which we believe ...
Redeye lowers its estimates for 2022 after a somewhat weaker Q1 than expected.
Redeye believes that the certification by Visa for Zwipe and some of its partners are a catalyst for...
Mangold inleder bevakning av prospekteringsbolaget Bluelake Mineral med rekommendationen Köp och ri...
Q1 NOI +4% vs ABGSCe EC rental income +14% q-o-q Public takeover likely to be successful First tak...
Redeye retains its positive view on Lagercrantz following the Q4 report showing an impressive 20% or...
Intellego meddelade under måndagen den 9 maj att bolaget ingått ett avtal med ett riskkapitalfinansi...
In our view, the Q1 report was a non-event, with the results broadly in line with our estimates.
Investors House reported Q1 revenue of EUR 1.8m, 16% below our estimate, mainly owing to Services, w...
Redeye states that Q1 came in below estimates and assesses that acceleration of product sales will l...
Kollect publicerade idag den 16 maj 2021 bolagets delårsrapport för första kvartalet 2022.
Redeye is encouraged to learn that aXichem will be collaborating with LIFEPro Nutrition and Indiex S...
Faron announced earlier today that the company’s New Drug (IND) application to initiate the phase I/...
Atria has sold its fast food business Sibylla Rus LLC to Agricultural Complex Mikhailovskiy, which i...
Den organiska tillväxten imponerar... Nettoomsättningen uppgick till 524 mkr vilket motsvarar en til...
